Valeritas & #226; �(TM) V-Go & #194; & #174; Wearable Insulin Delivery Device ...

BRIDGEWATER, N.J., April 26, 2019 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of V-Go® Wearable Insulin Delivery device, today announced results from the VERDICT study at the American Association of Clinical Endocrinologists (AACE) Annual Meeting. The VERDICT study demonstrated that patients with type 2 diabetes who switched to V-Go can improve their average blood sugar levels (A1c) with less insulin. VERDICT is a...This story is related to the following:Medical Devices
Source: Industrial Newsroom - Health, Medical and Dental Supplies - Category: Medical Devices Source Type: news